LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical
device company, today announced that President and Chief Executive
Officer Brad Mason will present at the J.P. Morgan Healthcare Conference
in San Francisco on Thursday, January 11, 2018 at 8:30 a.m. PT.
A live audio webcast will be available on the Company's website at ir.orthofix.com/events.cfm.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, TX, the Company has
four strategic business units: BioStim, Biologics, Extremity Fixation
and Spine Fixation. Orthofix products are widely distributed via the
Company's sales representatives, distributors and subsidiaries. In
addition, Orthofix is collaborating on research and development
activities with leading clinical organizations such as Brown University,
Sinai Hospital of Baltimore, Cleveland Clinic, Texas Scottish Rite
Hospital for Children, and MTF Biologics. For more information, please
visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180102005864/en/
Orthofix International N.V.
Investor Contact:
Mark
Quick, 214-937-2924
markquick@orthofix.com
or
Media
Contact:
Denise Landry, 214-937-2529
deniselandry@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media